Show/hide main menu


News Highlights

PhD Student Wins MRC Science Writing Award

Posted on 10/10/2013

MRC PhD student Clare Finlay from the Wolfson Centre for Age-Related Diseases was the runner-up in this year’s Max Perutz Science Writing Award. She received the £1,000 prize for her article explaining her research looking at ways to stop dopamine-producing brain cells from dying in Parkinson’s disease.

Clare received her writing prize on 25 September 2013 during an award ceremony at the Science Museum, London, introduced by Minister of State for Universities and Science, David Willetts MP.

The awards were announced by MRC Chairman and competition judge, Donald Brydon. The other judges included: Jon Snow, Channel 4 newscaster; Roger Highfield, Director of External Affairs at the Science Museum and former New Scientist editor; Lizzie Gibney, Times Higher Education reporter; and last year’s award winner Dr Andrew Bastawrous. 

Members of the MRC’s Council and Management Board as well as colleagues from across the medical research community had the opportunity to congratulate the shortlisted entrants and meet the judges.  A commendation prize of £750 was also awarded to King’s student Nick Dand, from the Division of Medical & Molecular Genetics.

The Max Perutz Award is in its 16th year and encourages MRC-funded researchers to communicate their work to a wider audience. Entrants are asked to explain why their research matters in just 800 words. On the MRC’s website, the award is described as being named ‘in honour of one of the UK’s most outstanding scientists and communicators, Dr Max Perutz.’

Clare’s PhD is funded through an MRC Industrial CASE studentship with Lilly UK, and her supervisor is Dr Susan Duty, Reader in Pharmacology & Neuroscience.

Read Clare’s winning article - A step in the right direction for Parkinson’s disease treatment? – on the MRC’s website.

Rss Feed Atom Feed

News Highlights:

News Highlights...RSS FeedAtom Feed

New class of drug shows promise for treating asthma and COPD

New class of drug shows promise for treating asthma and COPD

Scientists have developed a new drug (RPL554) that could treat obstructive airway diseases such as asthma and chronic obstructive pulmonary disease (COPD) in two ways at once, according to new research published in The Lancet Respiratory Medicine.
Key mechanism links exercise to muscle growth

Key mechanism links exercise to muscle growth

Scientists from King's College London have identified a mechanism by which exercise – or lack of it – controls the growth and loss of muscle mass.
Michael Levitt wins Nobel Prize for Chemistry

Michael Levitt wins Nobel Prize for Chemistry

King's College London is today celebrating the award of the 2013 Nobel Prize in Chemistry to its alumnus Professor Michael Levitt FRS.

Share this story:

Sitemap Site help Terms and conditions Privacy policy Accessibility Modern slavery statement Contact us

© 2017 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454